Residency Research

Our residents have the option to spend a full academic year in their third or fourth year of residency as a research resident. Permission to do a research year is highly competitive and requires that the resident attend and present at several research conferences throughout the year. Research residents have the opportunity to explore a variety of research within our divisions, and often present their work at local, regional, national and international meetings.

How to apply

Residents interested in research must choose a primary mentor from the Department of Surgery faculty, and then develop a research proposal. Applications for the Research Year are due by November 1 prior to the beginning of the Research Year. Once approved by the Research Committee, the residents will then complete one year of research under the direction of Belinda McCully, Ph.D. and Jonathan Brody, Ph.D. Additional research years are occasionally possible, as is research at external institutions. 

Contact Dr. Belinda McCully for more information on the program and how to apply.

Residency Research Leadership

Belinda McCully, Ph.D., Resident Research Director

Belinda McCully, Ph.D., is a Research Assistant Professor in the Division of Surgical Oncology and Director of Resident Research for the Department of Surgery. Her research focuses on the contribution of autonomic and vascular dysfunction to adverse clinical outcomes in surgical patients.

Jonathan Brody, Ph.D., Vice Chair for Surgery Research

Jonathan Brody, Ph.D., is the Vice Chair of Research for the Dept. of Surgery and is the Assoc. Director of the Brenden-Colson Pancreatic Center for Patient Care. He was a member and co-leader of the GI Cancer Program at the Sidney Kimmel Cancer Center (Thomas Jefferson University). Dr. Brody received his Ph.D. from The Johns Hopkins University School of Medicine, and his thesis specialized in studying the molecular aspects of cancer and cancer genetics. He patented, with Dr. Scott Kern, novel buffers for DNA identification (DNA electrophoresis buffer), that have changed the format of this molecular biology technique used to detect DNA. He was elected Chair of the Cancer Research Program (PRCRP), Department of Defense council and serves on many international study sections, including currently being the Chair of the Tumor Biology and Genomics study section for the American Cancer Society and a permanent member of the Cancer Prevention Study Section NCI study section panel. He has published over 135 peer review publications in many top tier scientific and cancer journals. Additionally, he was an American Cancer Society Research Scholar, is NIH (NCI, R01) funded, and won the American Association of Cancer Research, Pancreatic Cancer Career Development Award in 2010.  His lab focuses on many molecular aspects of pancreatic cancer, including developing ways to target a novel pro-survival network in pancreatic cancer cells and optimizing current targeted therapies used in the clinic (i.e., an interest in personalizing therapy for pancreatic cancer patients, PanCAN, RAN grant PI).  Specifically, his lab is focused on an RNA binding protein, HuR, that is a involved in regulating a pro-survival network in various microenvironment settings involved with pancreatic cancer and targeting the DNA repair pathway (i.e., BRCAness) in pancreatic cancer.

Past Research Resident Publications